Swiss maker of laboratory automation systems and liquid-handling robots for life-science and diagnostics labs.
Swiss maker of laboratory automation systems and liquid-handling robots for life-science and diagnostics labs.
Sells its own-brand lab instruments, followed by a recurring stream of consumables such as disposable pipette tips, service and software. A second business builds instruments and modules that diagnostics makers sell under their own names, so a few partners carry large volumes.
In one line: A smaller Swiss Agilent for lab automation.
Moat: narrow (installed base, switching costs, IP / patents). Deep integration into lab workflows and OEM contracts create switching costs.
Headquarters: Mannedorf, Switzerland · Founded: 1980 · Employees: 3,244
Size Tecan (TECN.SW) is a Switzerland Health Care company (Medical Specialties) with a market value of $3.60B, the 68th largest of 155 Switzerland companies the cockpit tracks. Shares closed at CHF 237.00 on 18 Nov 2026.
Performance Over six months the shares gained 59.0%, against -0.4% for the median peer and +9.3% for the Switzerland market (cap-weighted) — 3rd highest of 21 in its peer set.
Growth Revenue fell 4.0% over the last twelve months (peer median +7.4%); the operating margin is 1.4% (peer median 12.0%).
Valuation It trades at 35.5× forward earnings against a peer median of 23.7× (6th most expensive of 19).
Price implies For today's price to make sense, revenue must grow about 45% a year for seven years (Req g). Recent delivered growth is +4%, so the hurdle is +42 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 4.9 points below its cost of capital (5.7% WACC).
Next results Next results expected around 16 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CHF 871M | CHF 882M | CHF 934M | CHF 1.07B | CHF 1.14B |
| Revenue growth | — | -6% | -13% | -6% | — |
| Gross profit | CHF 297M | CHF 280M | CHF 282M | CHF 359M | CHF 405M |
| EBITDA | CHF 69.9M | CHF 86.2M | CHF 141M | CHF 202M | CHF 213M |
| Net income | -CHF 116M | -CHF 111M | CHF 67.7M | CHF 132M | CHF 121M |
| Free cash flow | CHF 79.4M | CHF 124M | CHF 136M | CHF 145M | CHF 104M |
| Capital expenditure | CHF 53.6M | CHF 35.3M | CHF 30.7M | CHF 34.9M | CHF 36.2M |
| Total debt | n/a | CHF 219M | CHF 322M | CHF 317M | CHF 308M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Tecan TECN.SW | $3.60B | +59% | -4% | 1% | 35.5× | 45.4% |
| Agilent Technologies A | $50.0B | +56% | +9% | 24% | 27.0× | 23.3% |
| Thermo Fisher Scientific TMO | $257B | +53% | +8% | 19% | 25.7× | 21.3% |
| Sartorius SRT.DE | $19.9B | +26% | +4% | 18% | 43.0× | 25.6% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | TECN.SW | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -2.9% | +3.5% | 9th lowest of 21 |
| 6-month return | +59.0% | -0.4% | 3rd highest of 21 |
| Distance from 52-week high | -14.8% | -27.7% | 6th highest of 21 |
| Revenue growth (TTM) | -4.0% | +7.4% | 2nd lowest of 21 |
| Operating margin | 1.4% | 12.0% | 6th lowest of 20 |
| Forward P/E | 35.5× | 23.7× | 6th most expensive of 19 |
| Growth the price implies (Req g, 7 yrs) | 45.4% | 10.0% | 3rd most demanding of 18 |
| Growth delivered (Del g) | +3.8% | +8.9% | 6th lowest of 18 |
| Hurdle (Req g minus delivered) | +41.5 pp | +1.0 pp | 2nd most demanding of 18 |
| ROIC minus cost of capital | -4.9 pp | -1.0 pp | 6th lowest of 19 |
| EV / EBITDA | 43.4× | 12.5× | 2nd most expensive of 10 |
| Net debt / EBITDA | -0.1× | 1.0× | 3rd least indebted of 11 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Tecan TECN.SW | Switzerland | $3.60B | +59% | -4% | 1% | 35.5× | 45.4% | +3.8% |
| Shandong Weigao Blood Purification Products 603014.SS | China | $3.63B | -1% | +4% | n/a | 20.4× | -1.2% | +8.1% |
| Sumitomo Bakelite 4203.T | Japan | $3.50B | +7% | +15% | 13% | 15.9× | 8.6% | +8.9% |
| SCHOTT Pharma AG & Co. KGaA 1SXP.DE | Germany | $3.73B | +32% | +4% | 15% | 23.0× | 12.7% | +11.0% |
| Ambu A/S AMBU-B.CO | Denmark | $3.47B | +31% | +7% | 13% | 28.8× | 10.0% | +10.0% |
| Envista NVST | United States | $3.81B | 0% | +10% | 12% | 14.7× | 4.8% | +7.1% |
| Axogen AXGN | United States | $3.40B | +33% | +24% | -5% | 87.3× | 52.6% | +14.9% |
| Pulse Biosciences PLSE | United States | $3.37B | +76% | +1,637% | -5,821% | n/a | n/a | n/a |
| Andon Health 002432.SZ | China | $3.86B | -24% | -30% | -26% | 16.1× | -6.6% | -7.4% |
| Autobio Diagnostics 603658.SS | China | $3.36B | +16% | +3% | 25% | 20.3× | -0.4% | +7.2% |
| TransMedics TMDX | United States | $3.35B | +42% | +28% | 12% | 43.4× | 38.4% | +88.2% |
| CareDx CDNA | United States | $3.91B | +252% | +39% | 1% | 50.6× | n/a | n/a |
| Fielmann FIE.DE | Germany | $3.92B | -3% | +3% | 14% | 17.1× | -5.5% | +11.3% |
| iRay Technology 688301.SS | China | $3.31B | -30% | +58% | 24% | 25.7× | n/a | n/a |
| Zhende Medical 603301.SS | China | $3.26B | -10% | +8% | 7% | 42.5× | 22.9% | -16.1% |
| Lepu Medical Technology (Beijing) 300003.SZ | China | $3.20B | -13% | -1% | 13% | 24.4× | 8.7% | -4.2% |
| iRhythm IRTC | United States | $3.19B | -19% | +22% | 5% | 99.8× | 46.9% | +23.0% |
| Carl Zeiss Meditec AFX.DE | Germany | $3.17B | +22% | 0% | 8% | 24.4× | 12.5% | +10.8% |
| Jiangsu Yuyue Medical Equipment & Supply 002223.SZ | China | $4.18B | -3% | -1% | 13% | 20.0× | 4.9% | +3.4% |
| Stevanato STVN | United States | $4.19B | -13% | +12% | 18% | 22.5× | 13.1% | +12.1% |
| MGI Tech 688114.SS | China | $3.06B | -4% | +2% | -7% | n/a | 43.7% | -0.1% |